GMSbiotech (GMS) has developed products to penetrate the new and rapidly growing genetics and
personalized medicine marketplace based on the development of its unique microarray technology
The Human Leukocyte Antigen (HLA) genes are those which are responsible for detecting foreign substances and triggering the immune system. Such HLA screening includes the detection of drug molecules, bacteria and viruses as well as the
process of self recognition.
Applied genetics is unique in laboratory medicine in terms of the extensive sample preparation and subsequent sample QC required before analysis can be initiated. Some estimates suggest that the "DNA purification problem" can contribute to increased costs, delays, and repeats due to poor sample quality or quantity.
GMSbiotech has developed products to penetrate the new and rapidly growing genetics and personalized medicine marketplace, based on the development of its unique microarray technology. The beach-head product in this market is "EZMatch™ test" which is based on Human Leukocyte Antigen (HLA) typing for the transplantation market.
